UK markets closed

Evgen Pharma plc (EVG.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
4.5500+0.1500 (+3.41%)
At close: 04:35PM GMT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
31/03/2019
Total revenue
0
0
194
0
0
Operating expenses
Research development
1,699
1,446
2,011
1,699
1,689
Selling general and administrative
565
564
635
565
499
Total operating expenses
3,889
3,191
3,398
3,146
3,120
Operating income or loss
-3,889
-3,191
-3,204
-3,146
-3,120
Income before tax
-3,845
-3,169
-3,213
-3,166
-3,120
Income tax expense
-490
-439
-539
-451
-496
Income from continuing operations
-3,355
-2,730
-2,674
-2,715
-2,624
Net income
-3,355
-2,730
-2,674
-2,715
-2,624
Net income available to common shareholders
-3,355
-2,730
-2,674
-2,715
-2,624
Basic EPS
-
-0.01
-0.02
-0.02
-0.03
Diluted EPS
-
-0.01
-0.02
-0.02
-0.03
Basic average shares
-
274,888
147,020
131,232
97,278
Diluted average shares
-
274,888
147,020
131,232
97,278
EBITDA
-
-3,175
-3,186
-3,125
-3,099